Target intelligence / Profile preview

Daboia siamensis venom C-type lectin-like protein (Snaclec)

Target
Snaclec
Molecular classification
C-type lectin, Snake venom toxin, Hemotoxic protein
01

Overview

Daboia siamensis venom C-type lectin-like proteins, commonly referred to as Snaclecs, are a major class of non-enzymatic toxins found in the venom of the Eastern Russell's Viper (Tan et al., 2014, Journal of Proteomics). These proteins typically exist as heterodimers and function by binding with high affinity to various components of the human hemostatic system, including platelet receptors like Glycoprotein Ib and blood coagulation factors such as Factor X and Factor IX (Clemetson, 2010, Toxicon). By interfering with these pathways, they induce or inhibit platelet aggregation and contribute to the severe consumptive coagulopathy and systemic hemorrhage characteristic of Russell's viper envenomation (WHO, 2016, Guidelines for the Management of Snakebites). In a clinical context, these toxins are the primary targets for neutralization by monovalent and polyvalent antivenoms produced by institutions like the Thai Red Cross Society. The interaction between the antivenom antibodies and the Snaclecs prevents the toxins from reaching their physiological targets, thereby halting the progression of venom-induced effects. Furthermore, due to their potent and specific interactions with the vascular system, they serve as valuable tools in hematological research and as templates for the development of novel anticoagulant or antiplatelet therapeutics (UniProt, 2024).

Other names
C-type lectin-like proteinCLPRussell's viper C-type lectinSiamensinSnake C-type lectin
02

Mechanism of action

Neutralization of toxin activity through antibody-antigen binding, which prevents the toxin from interacting with physiological targets such as platelet receptors and coagulation factors (WHO, 2016).

03

Biological functions

Platelet aggregation inductionPlatelet aggregation inhibitionCoagulation factor X bindingCoagulation factor IX bindingHemostasis disruption
04

Disease associations

Snakebite envenomationConsumptive coagulopathyThrombocytopeniaHemorrhageDisseminated intravascular coagulation
05

Safety considerations

Antivenom-induced anaphylaxisSerum sicknessGeographic variation in venom composition affecting antivenom efficacyIncomplete neutralization of specific toxin isoforms
06

Interacting drugs

Daboia siamensis Antivenom

2 more in the full profile.

07

Biomarkers

Prothrombin time (PT)Activated partial thromboplastin time (aPTT)Platelet countFibrinogen levels20-minute whole blood clotting test (20WBCT)

Beyond the preview

Go deeper on Daboia siamensis venom C-type lectin-like protein (Snaclec).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daboia siamensis venom C-type lectin-like protein (Snaclec).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call